SEC Comment Letter for LifeMD, Inc. (LFMD, LFMDP) (CIK 0000948320) (LFMD) — Jul 9, 2018
LifeMD, Inc. (LFMD, LFMDP) (CIK 0000948320)
Date: July 9, 2018 · CIK: 0000948320 · Accession: 0000000000-18-020941
AI Filing Summary & Sentiment
File numbers found in text: 333-225920
Letter
July 9, 2018 Justin Schreiber Chief Executive Officer Conversion Labs, Inc. 1460 Broadway New York, NY Re:Conversion Labs, Inc. Registration Statement on Form S-1 Filed June 27, 2018 File No. 333-225920 Dear Mr. Schreiber: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Lawrence Metelitsa, Esq.
Show Raw Text
July 9, 2018
Justin Schreiber
Chief Executive Officer
Conversion Labs, Inc.
1460 Broadway
New York, NY
Re:Conversion Labs, Inc.
Registration Statement on Form S-1
Filed June 27, 2018
File No. 333-225920
Dear Mr. Schreiber:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Lawrence Metelitsa, Esq.